Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Melo

Showing results (61-70 of 330) with videos related to

Pageof 33
Sort By:
Science (New York, N.Y.)|September 22, 2001
Roots of clinical resistance to STI-571 cancer therapyC Barthe, P Cony-Makhoul, J V Melo, et al.
Nature Genetics|December 1, 1994
Lack of imprinting of the ABL geneJ V Melo, X H Yan, J Diamond, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2015
Connecting the dots: hypoxia, pulmonary fibrosis, obstructive sleep apnea, and agingNatalia C V Melo, Fabio F Amorim, Alfredo N C Santana
Leukemia|November 21, 2008
Reply to 'What do we mean by sensitivity when we talk about detecting minimal residual disease?' by Steinbach and DebatinD M Ross, S Branford, J V Melo, et al.
Leukemia|April 1, 1995
Balanced parental contribution to the ABL component of the BCR-ABL gene in chronic myeloid leukemiaJ V Melo, X H Yan, J Diamond, et al.
Hematology. American Society of Hematology. Education Program|November 10, 2001
Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic StrategiesHagop Kantarjian, Junia V. Melo, Sante Tura, et al.
Blood|November 14, 1997
The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cellsM W Deininger, J M Goldman, N Lydon, et al.
Seminars in Oncology|December 1, 1984
Hairy cell leukemia (HCL) variant: an intermediate disease between HCL and B prolymphocytic leukemiaD Catovsky, M O'Brien, J V Melo, et al.
FEBS Letters|March 14, 2007
Upregulation of the TGFbeta signalling pathway by Bcr-Abl: implications for haemopoietic cell growth and chronic myeloid leukaemiaGigi M O Møller, Victoria Frost, Junia V Melo, et al.
British Journal of Haematology|March 1, 1996
Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemiaJ V Melo, A Hochhaus, X H Yan, et al.
Pageof 33

Showing results (61-70 of 330) with videos related to

Sort By:
Pageof 33
Science (New York, N.Y.)|September 22, 2001
Roots of clinical resistance to STI-571 cancer therapyC Barthe, P Cony-Makhoul, J V Melo, et al.
Nature Genetics|December 1, 1994
Lack of imprinting of the ABL geneJ V Melo, X H Yan, J Diamond, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2015
Connecting the dots: hypoxia, pulmonary fibrosis, obstructive sleep apnea, and agingNatalia C V Melo, Fabio F Amorim, Alfredo N C Santana
Leukemia|November 21, 2008
Reply to 'What do we mean by sensitivity when we talk about detecting minimal residual disease?' by Steinbach and DebatinD M Ross, S Branford, J V Melo, et al.
Leukemia|April 1, 1995
Balanced parental contribution to the ABL component of the BCR-ABL gene in chronic myeloid leukemiaJ V Melo, X H Yan, J Diamond, et al.
Hematology. American Society of Hematology. Education Program|November 10, 2001
Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic StrategiesHagop Kantarjian, Junia V. Melo, Sante Tura, et al.
Blood|November 14, 1997
The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cellsM W Deininger, J M Goldman, N Lydon, et al.
Seminars in Oncology|December 1, 1984
Hairy cell leukemia (HCL) variant: an intermediate disease between HCL and B prolymphocytic leukemiaD Catovsky, M O'Brien, J V Melo, et al.
FEBS Letters|March 14, 2007
Upregulation of the TGFbeta signalling pathway by Bcr-Abl: implications for haemopoietic cell growth and chronic myeloid leukaemiaGigi M O Møller, Victoria Frost, Junia V Melo, et al.
British Journal of Haematology|March 1, 1996
Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemiaJ V Melo, A Hochhaus, X H Yan, et al.
Pageof 33